Skip to content
Open access

A multimodal radiomics, deep learning, and pathomics signature for predicting the prognosis in central conventional chondrosarcoma

Aug 2026 · Translational Oncology · Vol 72 · 0 citations · 37 references
Medicine

TL;DR

A multimodal signature integrated CT radiomics, deep learning, and pathomics combined to predict progression-free survival in independent cohorts and may support postoperative risk stratification.

Abstract

Highlights • Prognostic tools remain limited for central conventional chondrosarcoma.• A multimodal signature integrated CT radiomics, deep learning, and pathomics.• The signature predicted progression-free survival in independent cohorts.• The signature may support postoperative risk stratification.

Read PDF

Similar papers

Open access Aug 2026

Comment: Prediction of Survival in Surgically Treated Glioblastoma Multiforme Utilizing DTI and Contrast-Enhanced MRI

The authors are commend the authors for addressing the clinically important question of preoperative imaging biomarkers for survival prediction in glioblastoma (GBM), however, several methodological, data integrity concerns are raised.

Rohini Chaudhari, Varidh Katiyar, Sourabh Zambre · 0 citations
Open access Aug 2026

Unveiling the power of TIIC: A prognostic tool for esophageal adenocarcinoma

A novel TIIC signature score predicts esophageal adenocarcinoma prognosis with high accuracy and offers insights into immune response and immunotherapy potential for EAC patients.

Shao Gao, Bing-Yan Du, Yeju He et al. · 0 citations
Open access Aug 2026

Multivariable Radiomics Model for Predicting Programmed Death‐Ligand 1 Expression After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma

We aimed to develop models for predicting programmed death‐ligand 1 (PD‐L1) expression following neoadjuvant chemoradiotherapy (nCRT) in esophageal squamous cell carcinoma (ESCC) using a multifaceted approach that integrates traditional radiomics, deep learning, and machine learning.

Hyun Do Jung, Tae Hoon Lee, Byoung Hyuck Kim et al. · 0 citations
Editorial Open access Aug 2026

Radiomic phenotypes in nonmuscle‐invasive bladder cancer: A precision biomarker guiding therapy

Magnetic resonance imaging radiomics shows promise in guiding the selection of patients most likely to benefit from the use of immune checkpoint inhibitor therapy in patients with very‐high‐risk, nonmuscle‐invasive bladder cancer. This work arrives at a moment of rapid expansion in bladder‐sparing therapeutics, even as...

Colton H Walker, Navid Jabalameli, S. Rais-Bahrami · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.